Perma-Fix Northwest Richland, Inc., 51387-51389 [2021-19841]

Download as PDF Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices to intervene shall be served by the requestor or petitioner in accordance with 10 CFR 110.89(a), either by delivery, by mail, or filed with the NRC electronically in accordance with the NRC’s E-Filing rule (72 FR 49139; August 28, 2007, as amended at 77 FR 46562; August 3, 2012). Detailed guidance on making electronic submissions may be found in the Guidance for Electronic Submissions to the NRC and on the NRC website at https://www.nrc.gov/site-help/esubmittals.html. To comply with the procedural requirements of E-Filing, at least 10 days prior to the filing deadline, the participant should contact the Office of the Secretary by email at Hearing.Docket@nrc.gov, or by telephone at 301–415–1677, to (1) request a digital identification (ID) certificate, which allows the participant (or its counsel or representative) to digitally sign submissions and access the E-Filing system for any proceeding in which it is participating; and (2) advise the Secretary that the participant 51387 will be submitting a petition or other adjudicatory document (even in instances in which the participant, or its counsel or representative, already holds an NRC-issued digital ID certificate). Based upon this information, the Secretary will establish an electronic docket for the hearing in this proceeding if the Secretary has not already established an electronic docket. The information concerning this application for an export license follows. NRC EXPORT LICENSE APPLICATION Application Information Name of Applicant .............................................. Date of Application ............................................. Date Received .................................................... Application No ..................................................... Docket No ........................................................... ADAMS Accession No ........................................ Perma-Fix Northwest Richland, Inc. (PFNW). July 2, 2021. July 8, 2021. XW028. 11006420. ML21190A131. Description of Material Material Type ...................................................... Total Quantity ..................................................... End Use .............................................................. Country of Destination ........................................ Dated: September 9, 2021. For the Nuclear Regulatory Commission. David L. Skeen, Deputy Director, Office of International Programs. to BWXT Medical, Ltd., Canada. The NRC is providing notice of the opportunity to comment, request a hearing, and petition to intervene on PFNW’s application. [FR Doc. 2021–19840 Filed 9–14–21; 8:45 am] DATES: Submit comments by October 15, 2021. A request for a hearing or a petition for leave to intervene must be filed by October 15, 2021. BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Perma-Fix Northwest Richland, Inc. Nuclear Regulatory Commission. ACTION: Export license application; opportunity to provide comments, request a hearing, and petition for leave to intervene. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) received and is considering issuing an export license (XW029) requested by Perma-Fix Northwest Richland, Inc. (PFNW). On July 2, 2021, PFNW filed an application with the NRC for a license authorizing the export of low-level radioactive waste SUMMARY: VerDate Sep<11>2014 17:08 Sep 14, 2021 You may submit comments by any of the following methods; however, the NRC encourages electronic comment submission through the Federal Rulemaking website: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2021–0164. Address questions about Docket IDs in Regulations.gov to Stacy Schumann; telephone: 301–415–0624; email: Stacy.Schumann@nrc.gov. For technical questions contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Email comments to: Hearing.Docket@nrc.gov. If you do not receive an automatic email reply confirming receipt, then contact us at 301–415–1677. ADDRESSES: [Docket No. 11006421; NRC–2021–0164] khammond on DSKJM1Z7X2PROD with NOTICES Radioactive material consisting of liquid waste generated from medical isotope and radiopharmaceuticals production. The treated waste exported to Canada consists mainly of thermal treatment residual (ash) and some non-combustible metal. Authorization to export a total maximum quantity of waste will not exceed 1,379,102 kilograms. The maximum isotopic activity returned will be 3.99 TBq. Radionuclides potentially present in the waste include: Cd-115, Co-60, Cr-51, Cu-64, ln-115m, K-42, Mo-93m, Mo-99, Nb91m, Nb-92m, Nb-95, Nb-95m, Nb-96, Re-188, Sb-122, Sb-124, Ta-182, Ta-183, Tc-99m, W-185, W-187, W-188, and Zr-89. Disposal in Canada. Canada. Jkt 253001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 • Fax comments to: Secretary, U.S. Nuclear Regulatory Commission at 301– 415–1101. • Mail comments to: Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001, ATTN: Rulemakings and Adjudications Staff. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: Gary Langlie, Office of International Programs, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–287–9076, email: Gary.Langlie@nrc.gov. SUPPLEMENTARY INFORMATION: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to NRC–2021–0164 or Docket No. 11006421 when contacting the NRC about the availability of information for this action. You may obtain publicly available information E:\FR\FM\15SEN1.SGM 15SEN1 51388 Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices related to this action by the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2021–0164. • NRC’s Public Website: Go to https:// www.nrc.gov and search for XW029, Docket No. 11006421, or Docket ID NRC–2021–0164. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov. The export license application from PFNW is available in ADAMS under Accession No. ML21190A133. • Attention: The PDR, where you may examine and order copies of public documents, is currently closed. You may submit your request to the PDR via email at pdr.resource@nrc.gov or call 1– 800–397–4209 or 301–415–4737, between 8:00 a.m. and 4:00 p.m. (ET), Monday through Friday, except Federal holidays. B. Submitting Comments The NRC encourages electronic comment submission through the Federal Rulemaking website (https:// www.regulations.gov). Please include NRC–2021–0164 or Docket No. 11006421 in your comment submission. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC will post all comment submissions at https:// www.regulations.gov as well as enter the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. II. Discussion On July 8, 2021, the NRC received an application from PFNW requesting a specific license to export low-level radioactive waste to Canada. The application seeks authorization to export no greater than 1,379,102 kilograms and 3.99 terabecquerels (TBq) of liquid low-level radioactive waste generated from medical isotope and radiopharmaceuticals production. The application requests an expiration date of December 1, 2026. In accordance with section 110.70 paragraph (b) of title 10 of the Code of Federal Regulations (10 CFR) the NRC is providing notice of the receipt of the application; providing the opportunity to submit written comments concerning the application; and providing the opportunity to request a hearing or petition for leave to intervene, for a period of 30 days after publication of this notice in the Federal Register. A hearing request or petition for leave to intervene must include the information specified in 10 CFR 110.82(b). Any request for hearing or petition for leave to intervene shall be served by the requestor or petitioner in accordance with 10 CFR 110.89(a), either by delivery, by mail, or filed with the NRC electronically in accordance with the NRC’s E-Filing rule (72 FR 49139; August 28, 2007, as amended at 77 FR 46562; August 3, 2012). Detailed guidance on making electronic submissions may be found in the Guidance for Electronic Submissions to the NRC and on the NRC website at https://www.nrc.gov/site-help/esubmittals.html. To comply with the procedural requirements of E-Filing, at least 10 days prior to the filing deadline, the participant should contact the Office of the Secretary by email at Hearing.Docket@nrc.gov, or by telephone at 301–415–1677, to (1) request a digital identification (ID) certificate, which allows the participant (or its counsel or representative) to digitally sign submissions and access the E-Filing system for any proceeding in which it is participating; and (2) advise the Secretary that the participant will be submitting a petition or other adjudicatory document (even in instances in which the participant, or its counsel or representative, already holds an NRC-issued digital ID certificate). Based upon this information, the Secretary will establish an electronic docket for the hearing in this proceeding if the Secretary has not already established an electronic docket. The information concerning this application for an export license follows. NRC EXPORT LICENSE APPLICATION Application Information Name of Applicant ....................................... Date of Application ...................................... Date Received ............................................. Application No ............................................. Docket No .................................................... ADAMS Accession No ................................. Perma-Fix Northwest Richland, Inc. (PFNW). July 2, 2021. July 8, 2021. XW029. 11006421. ML21190A133. Description of Material khammond on DSKJM1Z7X2PROD with NOTICES Material Type ............................................... Total Quantity .............................................. End Use ....................................................... Country of Destination ................................. VerDate Sep<11>2014 18:00 Sep 14, 2021 Jkt 253001 Radioactive material consisting of liquid waste generated from medical isotope and radiopharmaceuticals production. The treated waste exported to Canada consists mainly of thermal treatment residual (ash) and some non-combustible metal. Authorization to export a total maximum quantity of waste will not exceed 1,379,102 kilograms. The maximum isotopic activity returned will be 3.99 TBq. Radionuclides potentially present in the waste include: Cd-115, Co-60, Cr-51, Cu-64, ln-115m, K-42, Mo-93m, Mo-99, Nb91m, Nb-92m, Nb-95, Nb-95m, Nb-96, Re-188, Sb-122, Sb-124, Ta-182, Ta-183, Tc-99m, W-185, W-187, W-188, and Zr-89. Disposal in Canada. Canada. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\15SEN1.SGM 15SEN1 51389 Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices Dated: September 9, 2021. For the Nuclear Regulatory Commission. David L. Skeen, Deputy Director, Office of International Programs. in the FOR FURTHER INFORMATION CONTACT section of this document. [FR Doc. 2021–19841 Filed 9–14–21; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket No. 50–482; NRC–2020–0110] Issuance of Exemption in Response to COVID–19 Public Health Emergency Nuclear Regulatory Commission. ACTION: Exemption; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) issued one exemption in August 2021 in response to a request from one licensee for relief due to the coronavirus 2019 disease (COVID–19) public health emergency (PHE). The exemption affords the licensee temporary relief from certain requirements under NRC regulations. DATES: On August 25, 2021, the NRC granted one exemption in response to a request submitted by one licensee on July 29, 2021, as supplemented by letter dated August 12, 2021. ADDRESSES: Please refer to Docket ID NRC–2020–0110 when contacting the NRC about the availability of information regarding this document. You may obtain publicly available information related to this document using any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2020–0110. Address questions about Docket IDs in Regulations.gov to Stacy Schumann; telephone: 301–415–0624; email: Stacy.Schumann@nrc.gov. For technical questions, contact the individual listed SUMMARY: • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov. For the convenience of the reader, instructions about obtaining materials referenced in this document are provided in the ‘‘Availability of Documents’’ section. • Attention: The PDR, where you may examine and order copies of public documents, is currently closed. You may submit your request for copies of documents to the PDR via email at pdr.resource@nrc.gov or call 1–800– 397–4209 or 301–415–4737, between 8:00 a.m. and 4:00 p.m. (ET), Monday through Friday, except Federal holidays. FOR FURTHER INFORMATION CONTACT: James Danna, Office of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–415–7422, email: James.Danna@nrc.gov. SUPPLEMENTARY INFORMATION: I. Introduction On August 25, 2021, the NRC granted one exemption in response to a request submitted by one licensee dated July 29, 2021, as supplemented by letter dated August 12, 2021. The exemption temporarily allows the licensee to deviate from certain requirements of chapter I of title 10 of the Code of Federal Regulations (10 CFR), part 50, appendix E, ‘‘Emergency Planning and Preparedness for Production and Utilization Facilities,’’ section IV.F, ‘‘Training.’’ The exemption grants Wolf Creek Nuclear Operating Corporation (for Wolf Creek Generating Station, Unit 1), a schedular exemption from the offsite biennial emergency preparedness (EP) exercise requirement, allowing it to postpone the calendar year 2021 fullparticipation biennial EP exercise until November 30, 2022, or when the required exercise is conducted in calendar year 2022, whichever occurs first. The exemption affords this licensee temporary relief from the requirements of 10 CFR part 50, appendix E, regarding offsite response organization (ORO) participation in the biennial EP exercise. The exemption will not adversely affect the emergency response capability of the facility because the licensee has conducted numerous drills, exercises, and other training activities that have exercised the licensee’s emergency response strategies since the last evaluated biennial EP exercise and that State, county, and local OROs have participated therein. The table in this notice provides transparency regarding the number and type of exemptions the NRC has issued. Additionally, the NRC publishes tables of approved regulatory actions related to the COVID–19 PHE on its public website at https://www.nrc.gov/aboutnrc/covid-19/reactors/licensingactions.html. II. Availability of Documents The table in this notice provides the facility name, docket number, document description, and ADAMS accession number for the exemption issued. Additional details on the exemption issued, including the exemption request submitted by the licensee and the NRC’s decision, are provided in the exemption approval listed in the table in this notice. For additional directions on accessing information in ADAMS, see the ADDRESSES section of this document. WOLF CREEK GENERATING STATION, UNIT 1, DOCKET NO. 50–482 ADAMS Accession No. khammond on DSKJM1Z7X2PROD with NOTICES Document description Wolf Creek Nuclear Operating Corporation—Docket No. 50–482: One-Time Request for Exemption from the Biennial Emergency Preparedness, dated July 29, 2021 ................................................................................................................................ Wolf Creek Nuclear Operating Corporation—Docket No. 50–482: Supplement to One-Time Request for Exemption from the Biennial Emergency Preparedness, dated August 12, 2021 ..................................................................................................... Wolf Creek Generating Station, Unit 1—Temporary Exemption from Requirements of 10 CFR part 50, appendix E, sections IV.F.2.B and IV.F.2.C (EPID L–2021–LLE–0036 [COVID–19]), dated August 25, 2021 .......................................................... VerDate Sep<11>2014 17:08 Sep 14, 2021 Jkt 253001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\15SEN1.SGM 15SEN1 ML21210A450 ML21224A225 ML21225A024

Agencies

[Federal Register Volume 86, Number 176 (Wednesday, September 15, 2021)]
[Notices]
[Pages 51387-51389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19841]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 11006421; NRC-2021-0164]


Perma-Fix Northwest Richland, Inc.

AGENCY: Nuclear Regulatory Commission.

ACTION: Export license application; opportunity to provide comments, 
request a hearing, and petition for leave to intervene.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) received and is 
considering issuing an export license (XW029) requested by Perma-Fix 
Northwest Richland, Inc. (PFNW). On July 2, 2021, PFNW filed an 
application with the NRC for a license authorizing the export of low-
level radioactive waste to BWXT Medical, Ltd., Canada. The NRC is 
providing notice of the opportunity to comment, request a hearing, and 
petition to intervene on PFNW's application.

DATES: Submit comments by October 15, 2021. A request for a hearing or 
a petition for leave to intervene must be filed by October 15, 2021.

ADDRESSES: You may submit comments by any of the following methods; 
however, the NRC encourages electronic comment submission through the 
Federal Rulemaking website:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2021-0164. Address 
questions about Docket IDs in Regulations.gov to Stacy Schumann; 
telephone: 301-415-0624; email: [email protected]. For technical 
questions contact the individual listed in the FOR FURTHER INFORMATION 
CONTACT section of this document.
     Email comments to: [email protected]. If you do not 
receive an automatic email reply confirming receipt, then contact us at 
301-415-1677.
     Fax comments to: Secretary, U.S. Nuclear Regulatory 
Commission at 301-415-1101.
     Mail comments to: Secretary, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555-0001, ATTN: Rulemakings and 
Adjudications Staff.
    For additional direction on obtaining information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Gary Langlie, Office of International 
Programs, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001; telephone: 301-287-9076, email: [email protected].

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to NRC-2021-0164 or Docket No. 11006421 when 
contacting the NRC about the availability of information for this 
action. You may obtain publicly available information

[[Page 51388]]

related to this action by the following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2021-0164.
     NRC's Public Website: Go to https://www.nrc.gov and search 
for XW029, Docket No. 11006421, or Docket ID NRC-2021-0164.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or 
by email to [email protected]. The export license application from 
PFNW is available in ADAMS under Accession No. ML21190A133.
     Attention: The PDR, where you may examine and order copies 
of public documents, is currently closed. You may submit your request 
to the PDR via email at [email protected] or call 1-800-397-4209 or 
301-415-4737, between 8:00 a.m. and 4:00 p.m. (ET), Monday through 
Friday, except Federal holidays.

B. Submitting Comments

    The NRC encourages electronic comment submission through the 
Federal Rulemaking website (https://www.regulations.gov). Please 
include NRC-2021-0164 or Docket No. 11006421 in your comment 
submission.
    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC will post all comment submissions at 
https://www.regulations.gov as well as enter the comment submissions 
into ADAMS. The NRC does not routinely edit comment submissions to 
remove identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment into ADAMS.

II. Discussion

    On July 8, 2021, the NRC received an application from PFNW 
requesting a specific license to export low-level radioactive waste to 
Canada. The application seeks authorization to export no greater than 
1,379,102 kilograms and 3.99 terabecquerels (TBq) of liquid low-level 
radioactive waste generated from medical isotope and 
radiopharmaceuticals production. The application requests an expiration 
date of December 1, 2026.
    In accordance with section 110.70 paragraph (b) of title 10 of the 
Code of Federal Regulations (10 CFR) the NRC is providing notice of the 
receipt of the application; providing the opportunity to submit written 
comments concerning the application; and providing the opportunity to 
request a hearing or petition for leave to intervene, for a period of 
30 days after publication of this notice in the Federal Register. A 
hearing request or petition for leave to intervene must include the 
information specified in 10 CFR 110.82(b). Any request for hearing or 
petition for leave to intervene shall be served by the requestor or 
petitioner in accordance with 10 CFR 110.89(a), either by delivery, by 
mail, or filed with the NRC electronically in accordance with the NRC's 
E-Filing rule (72 FR 49139; August 28, 2007, as amended at 77 FR 46562; 
August 3, 2012). Detailed guidance on making electronic submissions may 
be found in the Guidance for Electronic Submissions to the NRC and on 
the NRC website at https://www.nrc.gov/site-help/e-submittals.html.
    To comply with the procedural requirements of E-Filing, at least 10 
days prior to the filing deadline, the participant should contact the 
Office of the Secretary by email at [email protected], or by 
telephone at 301-415-1677, to (1) request a digital identification (ID) 
certificate, which allows the participant (or its counsel or 
representative) to digitally sign submissions and access the E-Filing 
system for any proceeding in which it is participating; and (2) advise 
the Secretary that the participant will be submitting a petition or 
other adjudicatory document (even in instances in which the 
participant, or its counsel or representative, already holds an NRC-
issued digital ID certificate). Based upon this information, the 
Secretary will establish an electronic docket for the hearing in this 
proceeding if the Secretary has not already established an electronic 
docket.
    The information concerning this application for an export license 
follows.

                     NRC Export License Application
------------------------------------------------------------------------
 
------------------------------------------------------------------------
                         Application Information
------------------------------------------------------------------------
    Name of Applicant........  Perma-Fix Northwest Richland, Inc.
                                (PFNW).
    Date of Application......  July 2, 2021.
    Date Received............  July 8, 2021.
    Application No...........  XW029.
    Docket No................  11006421.
    ADAMS Accession No.......  ML21190A133.
------------------------------------------------------------------------
                         Description of Material
------------------------------------------------------------------------
    Material Type............  Radioactive material consisting of liquid
                                waste generated from medical isotope and
                                radiopharmaceuticals production. The
                                treated waste exported to Canada
                                consists mainly of thermal treatment
                                residual (ash) and some non-combustible
                                metal.
    Total Quantity...........  Authorization to export a total maximum
                                quantity of waste will not exceed
                                1,379,102 kilograms. The maximum
                                isotopic activity returned will be 3.99
                                TBq. Radionuclides potentially present
                                in the waste include: Cd-115, Co-60, Cr-
                                51, Cu-64, ln-115m, K-42, Mo-93m, Mo-99,
                                Nb-91m, Nb-92m, Nb-95, Nb-95m, Nb-96, Re-
                                188, Sb-122, Sb-124, Ta-182, Ta-183, Tc-
                                99m, W-185, W-187, W-188, and Zr-89.
    End Use..................  Disposal in Canada.
    Country of Destination...  Canada.
------------------------------------------------------------------------



[[Page 51389]]

    Dated: September 9, 2021.

    For the Nuclear Regulatory Commission.
David L. Skeen,
Deputy Director, Office of International Programs.
[FR Doc. 2021-19841 Filed 9-14-21; 8:45 am]
BILLING CODE 7590-01-P